Related Experiment Videos
Structural characterization of a serendipitously discovered bioactive macromolecule, lignin sulfate
Arjun Raghuraman1, Vaibhav Tiwari, Jay N Thakkar
1Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298-0540, USA.
Biomacromolecules
|September 13, 2005
Summary
Researchers sought heparan sulfate mimics to block herpes simplex virus-1 (HSV-1) entry. They discovered a sulfated lignin polymer, not a flavonoid, effectively inhibits HSV-1 infection through multiple binding interactions.
Area of Science:
- Biochemistry
- Virology
- Polymer Science
Background:
- Herpes simplex virus-1 (HSV-1) infection relies on cell-surface heparan sulfate for cellular entry.
- Developing synthetic heparan sulfate mimics is a strategy to prevent HSV-1 infection.
Purpose of the Study:
- To identify potent inhibitors of HSV-1 infection by searching for synthetic heparan sulfate mimics.
- To characterize the active compound responsible for inhibiting HSV-1 infection.
Main Methods:
- Biophysical and chemical analyses were employed for compound identification.
- Mass spectrometry and elemental analysis characterized the lignin sulfate structure.
- High-performance size exclusion chromatography and polyacrylamide gel electrophoresis assessed molecular weight and polymer structure.
Main Results:
- Initial screening suggested a sulfated flavonoid inhibited HSV-1, but further analysis revealed the active component was a sulfated lignin polymer.
- Lignin sulfate, a polymer of p-coumaryl monomers linked by beta-O-4 linkages, was identified as the active principle.
- Characterization revealed a polydisperse polymer (1.5-40 kDa) with a highly networked structure, distinct from linear charged polymers.
Conclusions:
- Macromolecular lignin sulfate exhibits potent inhibitory activity against HSV-1 infection.
- Lignin sulfate's complex structure allows interactions with viral glycoproteins via hydrophobic, hydrogen-bonding, and ionic forces.
- Sulfated lignin represents a promising class of compounds with potential medicinal benefits for antiviral therapies.